Literature DB >> 26824378

Utility of arterial spin labeling perfusion magnetic resonance imaging in prediction of angiographic vascularity of meningiomas.

Roh-Eul Yoo1,2, Tae Jin Yun1,2, Young Dae Cho1,2, Jung Hyo Rhim1, Koung Mi Kang1,2, Seung Hong Choi1,2,3, Ji-Hoon Kim1,2, Jeong Eun Kim4, Hyun-Seung Kang4, Chul-Ho Sohn1,2,3, Sun-Won Park2,5, Moon Hee Han1,2,3.   

Abstract

OBJECTIVE Arterial spin labeling perfusion-weighted imaging (ASL-PWI) enables quantification of tissue perfusion without contrast media administration. The aim of this study was to explore whether cerebral blood flow (CBF) from ASL-PWI can reliably predict angiographic vascularity of meningiomas. METHODS Twenty-seven patients with intracranial meningiomas, who had undergone preoperative ASL-PWI and digital subtraction angiography prior to resection, were included. Angiographic vascularity was assessed using a 4-point grading scale and meningiomas were classified into 2 groups: low vascularity (Grades 0 and 1; n = 11) and high vascularity (Grades 2 and 3; n = 16). Absolute CBF, measured at the largest section of the tumor, was normalized to the contralateral gray matter. Correlation between the mean normalized CBF (nCBF) and angiographic vascularity was determined and the mean nCBF values of the 2 groups were compared. Diagnostic performance of the nCBF for differentiating between the 2 groups was assessed. RESULTS The nCBF had a significant positive correlation with angiographic vascularity (ρ = 0.718; p < 0.001). The high-vascularity group had a significantly higher nCBF than the low-vascularity group (3.334 ± 2.768 and 0.909 ± 0.468, respectively; p = 0.003). At the optimal nCBF cutoff value of 1.733, sensitivity and specificity for the differential diagnosis of the 2 groups were 69% (95% CI 41%-89%) and 100% (95% CI 72%-100%), respectively. The area under the receiver operating characteristic curve was 0.875 (p < 0.001). CONCLUSIONS ASL-PWI may provide a reliable and noninvasive means of predicting angiographic vascularity of meningiomas. It may thus assist in selecting potential candidates for preoperative digital subtraction angiography and embolization in clinical practice.

Entities:  

Keywords:  ASL-PWI = arterial spin labeling perfusion-weighted imaging; CBF = cerebral blood flow; DSA = digital subtraction angiography; ECA = external carotid artery; ICA = internal carotid artery; ROC = receiver operating characteristic; angiographic vascularity; arterial spin labeling; meningiomas; nCBF = normalized CBF; oncology; perfusion magnetic resonance imaging

Mesh:

Substances:

Year:  2016        PMID: 26824378     DOI: 10.3171/2015.8.JNS151211

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  4 in total

1.  Added Value of Arterial Spin-Labeling MR Imaging for the Differentiation of Cerebellar Hemangioblastoma from Metastasis.

Authors:  K M Kang; C-H Sohn; S-H You; J G Nam; S H Choi; T J Yun; R-E Yoo; J-H Kim
Journal:  AJNR Am J Neuroradiol       Date:  2017-09-14       Impact factor: 3.825

2.  Arterial spin labeling imaging correlates with the angiographic and clinical vascularity of vestibular schwannomas.

Authors:  Yujiro Tanaka; Michihiro Kohno; Takao Hashimoto; Nobuyuki Nakajima; Hitoshi Izawa; Hirofumi Okada; Norio Ichimasu; Ken Matsushima; Tomoya Yokoyama
Journal:  Neuroradiology       Date:  2020-01-09       Impact factor: 2.804

3.  Differentiation of Glioblastoma from Brain Metastasis: Qualitative and Quantitative Analysis Using Arterial Spin Labeling MR Imaging.

Authors:  Leonard Sunwoo; Tae Jin Yun; Sung-Hye You; Roh-Eul Yoo; Koung Mi Kang; Seung Hong Choi; Ji-Hoon Kim; Chul-Ho Sohn; Sun-Won Park; Cheolkyu Jung; Chul-Kee Park
Journal:  PLoS One       Date:  2016-11-18       Impact factor: 3.240

4.  Non-invasive qualitative and semiquantitative presurgical investigation of the feeding vasculature to intracranial meningiomas using superselective arterial spin labeling.

Authors:  Ulf Jensen-Kondering; Michael Helle; Thomas Lindner; Olav Jansen; Arya Nabavi
Journal:  PLoS One       Date:  2019-04-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.